Clinical Trials List
2023-07-07 - 2026-07-31
Phase I
Recruiting5
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
-
Trial Applicant
AbbVie
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yu-Min Yeh 無
- Seu-Chun Yang 無
- Chia-Jui Yen Division of Hematology & Oncology
- Jui-Hung Tsai 無
- Wu-Chou Su Division of Hematology & Oncology
- Shang-Yin Wu 無
- Chin-Wei Kuo 無
- Wen-Pin Su Division of Hematology & Oncology
- Chien-Chung Lin 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shih-Hsin Hsiao Division of Thoracic Medicine
- Shang-Fu Hsu Division of Thoracic Medicine
- Kai-Ling Lee Division of Thoracic Medicine
- Huan-Tze Lin Division of Thoracic Medicine
- Pai-Chien Chou Division of Thoracic Medicine
- Sheng-Yu Chen Division of Thoracic Medicine
- Chi-Li Chung Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
- Jia-Ruey Tsai Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ching-Shan Luo Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
- JING-QUAN ZHENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
62 participants
-
Global
512 participants
